Company news

Immuron Limited news in 2025

Immuron Limited's news releases, calls and decks from 2025, newest first.

View company

Uniformed Services University to Release Topline Data

December 9, 2025

Immuron New U.S. Department of Defense Award & Clinical Trial Update

December 3, 2025

Immuron IMM-529 IND approved by FDA

November 5, 2025

IMM-529 IND approved by FDA

November 5, 2025

Immuron Announces Clinical Trial Update

October 31, 2025

Clinical Trial Update

October 30, 2025

Immuron launch PROIBS for IBS

October 23, 2025

Presenting on Emerging Growth Conference 87 Day 1 on October 22. Register to live stream.

October 21, 2025

Immuron Q1 FY26 YoY growth

October 13, 2025

Immuron Submits IMM-529 IND to FDA

October 8, 2025

Immuron Letter to Shareholders – Projects Update

October 2, 2025

FY25 Results Presentation

August 28, 2025

Appendix 4E Preliminary Final Report

August 28, 2025

Immuron partners with InvestorHub

August 26, 2025

Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

August 20, 2025

Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

August 19, 2025

Immuron - FY25 global sales exceed projection, up 49% on prior year

July 17, 2025

FY25 global sales exceed projection, up 49% on prior year

July 16, 2025

Immuron Travelan® highest sales in history

April 10, 2025

Immuron Travelan highest sales in history

April 10, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS)

March 5, 2025

IMC and Calmino to treat Irritable Bowel Syndrome (IBS)

March 4, 2025

Immuron Travelan continued strong sales growth

January 16, 2025

Immuron Announces Travelan Clinical Trial Update

January 14, 2025

Decks in 2025